🇺🇸 FDA
Patent

US 10245255

Compositions and methods for the treatment of obesity and related disorders

granted A61KA61K31/436A61P

Quick answer

US patent 10245255 (Compositions and methods for the treatment of obesity and related disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/436, A61P, A61P1/16, A61P3/04